Interest in spermidine, a naturally occurring compound found in certain foods, is growing as research explores its potential benefits for weight management and healthy aging. Long popular among biohackers for its role in cellular recycling, spermidine is now being examined for its possible effects on obesity, liver health, and age-related diseases.
Spermidine is a polyamine compound initially identified in human semen, from which it derives its name, and later detected throughout the body. It occurs naturally in foods such as wheatgerm, mature cheeses, soybeans, mushrooms, and green peppers. Available as an over-the-counter supplement, spermidine typically comes in powder or capsule form at a relatively low cost.
Some social media users have promoted spermidine as a weight-loss aid, with anecdotal reports of significant weight reduction and improvements in skin quality. Former television host Carol Vorderman has publicly stated that she takes spermidine daily, believing it contributes to slowing the aging process.
Scientific interest centers on spermidine's ability to stimulate autophagy, a biological process that involves the degradation and recycling of damaged cellular components. Autophagy, which tends to decline with age, is thought to play a protective role against metabolic, liver, and cardiovascular diseases. Professor Arshad Rather, head of geriatric medicine at University College London Hospitals, explains that maintaining efficient autophagy could help counteract age-associated damage and diseases.
Recent human studies have highlighted possible associations between increased spermidine intake and health improvements. A study published in the European Journal of Nutrition tracked over 2,600 older adults in Spain with overweight or obesity and metabolic syndrome. Participants who increased their consumption of spermidine-rich foods over a year showed more pronounced improvements in liver function, blood glucose levels, cholesterol, body weight, and markers of fatty liver disease compared to those with lower intake.
In the UK, obesity is the leading driver of non-alcoholic fatty liver disease (NAFLD), which affects approximately one in three adults. While findings from the Spanish study are promising, Professor Rather cautions that they demonstrate correlation rather than causation, emphasizing the need for more rigorous clinical trials to confirm spermidine’s therapeutic effects.
Nutritionist Gabriela Peacock recommends simple dietary adjustments to increase spermidine intake, such as incorporating wheatgerm into yogurt or porridge, adding lentils or chickpeas to meals, regularly consuming mushrooms, and replacing refined grains with whole grains.
Animal research offers additional support, with a recent mouse study indicating that spermidine supplementation reduced liver scarring and markers of liver injury. However, it remains unclear whether supplements produce the same outcomes as spermidine obtained from food sources.
Further complexity arises from a 2022 Chinese study reporting that obese individuals had higher blood levels of spermidine than those of normal weight. Notably, participants with the highest spermidine levels were less likely to gain weight over the subsequent two years, suggesting that the compound might be part of the body’s response to metabolic stress related to obesity.
Overall, while initial research on spermidine points to potential health benefits regarding weight control, liver function, and aging, experts agree that more comprehensive studies are required to establish effective recommendations and clarify its role in human health.